Lars French

Company: Alys Pharmaceuticals

Job title: Chief Medical Officer

Seminars:

Panel Discussion: Personalized Medicine’s Place in Dermatology Drug Discovery 11:00 am

How can advancements in molecular profiling and biomarker identification facilitate the implementation of personalized medicine approaches in dermatological drug development? What challenges exist in translating personalized medicine concepts, such as pharmacogenomics and patient stratification, into actionable strategies for dermatology drug discovery? As a more personalized medicine approach narrows addressable patient population size, what do commercial…Read more

day: Day Two Discovery Track AM

Next Generation Drug Targeting in Dermatology: Alys Pharmaceuticals’ Pioneering Approach 4:00 pm

Optimal benefit/risk outcomes from state-of-the-art tissue and cell-level targeting strategies Molecular targeting to sidestep side effects: antibody vectorization for chronic spontaneous urticaria Truly sharp targeting: siRNA-based technology for inflammatory skin diseaseRead more

day: Conference Day One